IJDDP/
Editorial Board

Editorial Board

  • Editor-in-Chief

    • Prof. Dr.  Xin Wang

      Cardiovascular Sciences Division, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

      Research Interests:
      cardiovascular mechanisms and transformation; drug discovery; drug target screening; gene editing; regulatory mechanisms of signaling molecules.
      avatar img

  • Associate Editors-in-Chief

    • Prof.  Guanhua Du*

      Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

      Research Interests:
      drug discovery; high-throughput drug screening; neurologic and cardiovascular pharmacology.

      *Prof. Du is also serving as Senior Consulting Editorial Board Member

      avatar img

    • Dr.  Antony Adamson

      Genome Editing Unit Core Facility, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

      Research Interests:
      CRISPR; gene editing; modelling disease; mouse models; iPSCs.
      avatar img

  • Senior Consulting Board

    • Prof.  Baofeng Yang

      Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, China.

      Research Interests:
      cardiovascular diseases; myocardial ischemia; arrhythmia; heart failure; and related drug development.
      avatar img

    • Prof.  R. John Solaro

      Department of Physiology and Biophysics, College of Medicine, University of Illinois, Chicago, IL, USA.

      Research Interests:
      cardiac sarcomeres; kinase/phosphatase signaling; GPCR signaling in cardiac myocytes; genetic cardiomyopathy; cardiac myocyte mechanical signaling; sarcomere directed heart therapies.
      avatar img

    • Prof.  Jun-ichi Abe

      Department of Cardiology Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

      Research Interests:
      the mitogen-activated protein kinase (MAP) family and have sought the mechanisms responsible for oxidative; hyperglycemia; and hypoxic injury to the vascular endothelium and the heart.
      avatar img

    • Prof.  Yang K. Xiang

      Department of Pharmacology, University of California at Davis, Davis, CA, USA.

      Research Interests:
      neuropharmacology and toxicology; molecular; cellular; and biochemical toxicology; cardiovascular pharmacology.
      avatar img

    • Prof.  Darren Green

      Department of Renal Medicine, Northern Care Alliance NHS Foundation Trust, Salford, UK.

      Research Interests:
      cardiorenal; acute kidney injury; chronic kidney disease; renovascular disease; heart failure.
      avatar img

    • Prof.  Christopher Huang

      Physiological Laboratory, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.

      Research Interests:
      mechanisms of atrial and ventricular arrhythmia in genetically modified murine models for ion channel and metabolic abnormalities; explorations for possible therapeutic targets.
      avatar img

    • Prof.  Martin Schwartz

      Yale Cardiovascular Research Center, Department of Cardiovascular Medicine, Yale University, New Haven, CT, USA.

      Research Interests:
      integrin signaling; mechanotransduction; vascular biology.
      avatar img

    • Prof.  H. Llewelyn Roderick

      Laboratory of Experimental Cardiology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.

      Research Interests:
      excitation contraction coupling; excitation transcription coupling; cardiac epigenetics; heterocellular interactions.
      avatar img

  • Associate Editors

    • Prof.  Ming Lei

      Department of Pharmacology, University of Oxford, Oxford, UK.

      Research Interests:
      cardiovascular pharmacology; medicinal chemistry; neuropharmacology; signalling.
      avatar img

    • Prof.  Kaomei Guan

      Institute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.

      Research Interests:
      modeling developmental processes in vitro; iPS-based disease modeling; validation of new drug targets; establishment of different iPSC-based tissue models for in vitro drug testing.
      avatar img

    • Prof. Dr.  Anna Nicolaou

      Division of Pharmacy and Optometry, School of Health Sciences and Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

      Research Interests:
      bioactive lipids and lipidomics with emphasis on the molecular mechanisms that mediate the role of eicosanoids; endocannabinoids; ceramides and polyunsaturated fatty acids in inflammation; cellular communications and tissue responses.
      avatar img

    • Dr.  Karolina M. Stepien

      Adult Inherited Metabolic Diseases, Salford Royal NHS Foundation Trust, Salford M6 8HD, UK.

      Research Interests:
      lysosomal storage diseases; mucopolysaccharidosis; cardiovascular risk; fucosidosis; mucolipidosis I; II; III and IV; secondary mitochondrial dysfunction; transition process; GM1 gangliosidosis; hematopoietic stem cell transplantation; hormonal dysfunction.
      avatar img

  • Editorial Board Members

    • Prof.  Chern Ein Oon

      Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Penang, Malaysia.

      Research Interests:
      drug discovery; cancer therapeutics; sirtuins; colorectal cancer.
      avatar img

    • Prof.  Jiong-Wei Wang

      Cardiovascular Research Institute, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

      Research Interests:
      cardio-metabolic diseases, cardiac immunology, extracellular vesicles and nanomedicine.
      avatar img

    • Prof.  Rongxue (Rosie) Wu

      Department of Biological Sciences Division-Cardiology, University of Chicago, Chicago, IL, USA.

      Research Interests:
      cardiac ischemia reperfusion; cardiac microvascular biology; diabetic cardiomyopathy.
      avatar img

    • Prof.  Raquel Duarte

      Department of Internal Medicine, University of the Witwatersrand, Johannesburg, South Africa.

      avatar img

    • Dr.  Gina Galli

      Faculty of Biology, Medicine and Health, Universty of Manchester, Manchester, UK.

      Research Interests:
      the effects of prenatal hypoxia on heart cell structure, calcium regulation and metabolism.
      avatar img

    • Prof.  Baoxue Yang

      School of Basic Medical Sciences, Peking University, Beijing, China.

      Research Interests:
      research and development of new diuretic drugs; mechanism of kidney injury and repair; pathogenesis and drug development of polycystic kidney disease; physiological and pharmacological studies of urea channel protein and aquaporin.
      avatar img

    • Prof.  Kyungsun Heo

      Cardiovascular Pharmacology Lab, College of Pharmacy, Chunnam National University, Gwangju, South Korea.

      Research Interests:
      post-translational modification - SUMOylation and Ubiqutination; discovery drug targets and therapeutic drugs for vascular cell dysfunction (EC, SMC, and macrophages) in cardiovascular diseases (Atherosclerosis); discovery drug targets and therapeutic drugs for metabolic disorders (Diabetes and NAFLD, Non-Alcoholic Fatty Liver Disease); discovery molecular mechanism and therapeutic drugs for inflammatory diseases (Cytokine storms).
      avatar img

    • Prof.  Ricardo Mancera

      Curtin Health Innovation Research Institute and Curtin Institute for Computation, Curtin Medical School, Curtin University, Perth, Australia.

      Research Interests:
      molecular dynamics simulation; biological membranes; protein structure and dynamics; protein-protein and protein-ligand interactions; structure-based drug design.
      avatar img

    • Dr.  Halina Dobrzynski

      • 1. Department of Anatomy, Jagiellonian University Medical College, Kopernika 12, 31-034, Cracow, Poland.
      • 2. Division of Cardiovascular Sciences, The University of Manchester, Manchester, UK.
      Research Interests:
      cardiac conduction system; imaging; electrophysiology; ageing; heart failure; biology medicine and health.
      avatar img

    • Prof.  Christhunesa S. Christudass

      Department of Neurological Sciences, Christian Medical College – Vellore, Tamil Nadu, India.

      Research Interests:
      genetic risk factors in stroke; cancer stem cells (CSCs) in gliomas.
      avatar img

    • Dr.  Xuesong Li

      Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, China.

      Research Interests:
      epigenetic mechanism of cardiovascular diseases and related drug development.
      avatar img

    • Dr.  Andrea Ruiz Velasco Hernandez

      Paris Cardiovascular Research Center, Paris, France.

      avatar img

    • Prof.  Jianglin Fan

      Department of Molecular Pathology, Faculty of Medicine, Graduate School of Medical Sciences, University of Yamanashi, Yamanashi, Japan.

      Research Interests:
      transgenic and knock-out rabbits; atherosclerosis; hypercholesterolemia; lipid metabolism; inflammation; macrophages.
      avatar img

    • Dr.  Nader Abo-Dya

      • 1. Faculty of pharmacy, Zagazig university, Zagazig, Egypt
      • 2. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tabuk University, Tabouk University, Tabuk, Saudi Arabia.
      Research Interests:
      molecular docking; chemical organic synthesis; medicinal and pharmaceutical chemistry; pharmaceutical development; drug discovery.
      avatar img

    • Dr.  James O'Byrne

      • 1. National Centre for Inherited Metabolic Disorders, Mater Misericordiae University Hospital, Dublin, Ireland.
      • 2. School of Medicine, University College Dublin, Dublin, Ireland.Trinity College Dublin, Dublin, Ireland.
      Research Interests:
      inherited metabolic disorders; precision medicine; education in genomic/ precision medicine.
      avatar img

    • Dr.  Assel Tulebayeva

      Kazakh National Medical University, Almaty, Kazakhstan.

      avatar img

    • Prof.  Suowen Xu

      Clinical Research Hospital of Chinese Academy of Sciences (Hefei), University of Science and Technology of China, Hefei 23001, China.

      Research Interests:
      pathogenesis of metabolic and cardiovascular diseases.
      avatar img